● Recruiting
Phase II
Infectious Disease
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
What is being tested: AZD4144, an investigational drug being evaluated for its efficacy, safety, and tolerability in treating sepsis-associated acute kidney injury (AKI), a…
05 May 2026
NCT07215702